Icon
+91 94997 68112
Login Register

TEKAMLO - (150MG;5MG, 150MG;10MG, 300MG;5MG, 300MG;10MG)

ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE None
150MG;5MG, 150MG;10MG, 300MG;5MG, 300MG;10MG
Less Than $1000 mn
None None
None None
None None
Tekamlo is a combination of aliskiren, a renin inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, indicated for the treatment of hypertension, to lower blood pressure:  As initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.  In patients not adequately controlled with monotherapy.  As a substitute for its titrated components.
Yes
TEKAMLO Patent 1 Patent 2
*** *********

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.